Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.01 USD
Change Today +0.0051 / 85.33%
Volume 20.4K
DGEN On Other Exchanges
As of 8:10 PM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

1900 South Norfolk Street

Suite 105

San Mateo, CA 94403

United States

Phone: 650-345-7601


Deltagen, Inc. provides drug discovery tools to the biopharmaceutical industry and the academic research community in the United States. The company licenses its inventory of knockout mouse lines and related phenotypic data. In addition, it offers target validation data in the areas of immunology and metabolic diseases. The company’s proprietary database, DeltaBase, provides information, based on knockout mouse studies, on gene function and validated gene targets for drug discovery. DeltaBase contains phenotypic data on 750 different knockout mouse lines. In addition to those 750 knockout mouse lines, Deltagen has approximately 150 additional knockout mouse lines that have not been characterized phenotypically. Deltagen also has approximately 450 knockout lines at the embryonic stem (ES) cell stage. The company’s DeltaOne product offers access to its portfolio of knockout mice and/or accompanying phenotypic data, as well as any corresponding intellectual property, on a gene-by-gene basis. The company’s customers and partners/collaborators include various pharmaceutical companies, such as GlaxoSmithKline plc; Merck & Co., Inc.; Pfizer, Inc.; Eli Lilly and Company; and Schering-Plough Research Institute. The company also sells its knockout mouse lines and related phenotypic data in Japan, China, and South Korea. History Deltagen, Inc. was founded in 1997.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DGEN:US $0.01 USD +0.0051

DGEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DGEN.
View Industry Companies

Industry Analysis


Industry Average

Valuation DGEN Industry Range
Price/Earnings 2.3x Not meaningful
Price/Sales 0.4x
Price/Book 0.2x
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DELTAGEN INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at